MedWatch

Novo Nordisk Foundation grants EUR 300m to new research center

The Novo Nordisk Foundation's biggest research center investment to date, a sum of EUR 300m, will enable future stem cell research. The grant supports the dream of curing chronic diseases, says Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation.

Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation | Photo: Gregers Tycho/ERH

An investment of EUR 300m over ten years has been granted to a new international stem cell research center, dubbed Renew – the sum is the biggest grant that the Novo Nordisk Foundation has ever given to a research center, Danish media Berlingske reports.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs